Trademark: 90275578
Word
STILLWATER PROGRAM
Status Date
Tuesday, January 16, 2024
Filing Date
Friday, October 23, 2020
Published for Opposition
Tuesday, May 24, 2022
44 Providing medical information relating to therapies and treatments for epilepsy and central nervous system diseases and disorders
42 Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of epilepsy and central nervous system diseases and disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders, and evaluating epidemiological results for treatments for epilepsy and central nervous system diseases and disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for epilepsy and central nervous system diseases and disorders
The mark consists of a stylized yellow sun over three horizontal blue lines all atop the stylized word "STILLWATER" in blue which is above the stylized word "PROGRAM" in blue.
The color(s) yellow and blue is/are claimed as a feature of the mark.
"PROGRAM"
Jan 18, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 16, 2024
Sou Extension 3 Granted
Jan 16, 2024
Sou Extension 3 Filed
Jan 16, 2024
Sou Teas Extension Received
Jul 7, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 5, 2023
Sou Extension 2 Granted
Jul 5, 2023
Sou Extension 2 Filed
Jul 5, 2023
Sou Teas Extension Received
Jan 10, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 6, 2023
Sou Extension 1 Granted
Jan 6, 2023
Sou Extension 1 Filed
Jan 6, 2023
Sou Teas Extension Received
Jul 19, 2022
Noa E-Mailed - Sou Required From Applicant
May 24, 2022
Official Gazette Publication Confirmation E-Mailed
May 24, 2022
Published For Opposition
May 4, 2022
Notification Of Notice Of Publication E-Mailed
Apr 18, 2022
Assigned To Lie
Apr 14, 2022
Approved For Pub - Principal Register
Feb 22, 2022
Suspension Checked - To Attorney For Action
Jul 26, 2021
Notification Of Letter Of Suspension E-Mailed
Jul 26, 2021
Letter Of Suspension E-Mailed
Jul 26, 2021
Suspension Letter Written
Jun 22, 2021
Teas/Email Correspondence Entered
Jun 21, 2021
Correspondence Received In Law Office
Jun 21, 2021
Teas Response To Office Action Received
Dec 19, 2020
Notification Of Non-Final Action E-Mailed
Dec 19, 2020
Non-Final Action E-Mailed
Dec 19, 2020
Non-Final Action Written
Dec 15, 2020
Assigned To Examiner
Dec 15, 2020
Notice Of Design Search Code E-Mailed
Dec 14, 2020
New Application Office Supplied Data Entered
Oct 27, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
